Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe

Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe

Upworthy

Published

Tuesday, the European Commission approved Roche Holdings AG’s RHHBY Tecentriq SC (atezolizumab), the European Union (EU) ‘s first PD-(L)1 cancer immunotherapy for subcutaneous (under the skin) injection. Last year, more than 38,000 people in the EU received Tecentriq to treat different types of…

#europeancommission #rocheholdingsags #rhhbytecentriqsc #tecentriq #iv #tecentriqiv #levigarraway #roche #givingtecentriq #tecentriqsc

Full Article